CIK: 0001977548 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $320,096 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | 128,300 | $4,465 | 1.4% | $72.48 | +8.4% | CALL | 218352102 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RYTM | RHYTHM PHARMACEUTICALS INC | 992,200 (+29.9%) | $106,205 (+37.7%) | 33.2% | $57.26 | +85.2% | COM | 76243J105 |
| CORT | CORCEPT THERAPEUTICS INC | 401,395 (+2.3%) | $13,969 (-57.2%) | 4.4% | $72.48 | +8.4% | COM | 218352102 |
| CYTK | CYTOKINETICS INC | 166,823 (+343.8%) | $10,600 (+413.1%) | 3.3% | $57.47 | +8.2% | COM NEW | 23282W605 |
| IRON | DISC MEDICINE INC | 452,992 (+5.3%) | $35,972 (+26.6%) | 11.2% | $58.37 | +44.8% | COM | 254604101 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| CRNX | CRINETICS PHARMACEUTICALS IN | 260,000 | $10,829 | 3.4% | $31.97 | +39.2% | — | 22663K107 |
| SEPN | SEPTERNA INC | 283,158 | $5,326 | 1.7% | $11.42 | +109.2% | — | 81734D104 |
| STOK | STOKE THERAPEUTICS INC | 212,049 | $4,983 | 1.6% | $17.13 | +75.5% | — | 86150R107 |
| KYMR | KYMERA THERAPEUTICS INC | 61,750 | $3,495 | 1.1% | $41.40 | +63.1% | — | 501575104 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ARGX | ARGENX SE | 142,000 (-5.3%) | $119,415 (+7.9%) | 37.3% | $464.20 | — | SPONSORED ADR | 04016X101 |
| RVMD | REVOLUTION MEDICINES INC | 370,000 (-24.8%) | $29,471 (+28.2%) | 9.2% | $42.98 | +52.6% | COM | 76155X100 |